Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity

Myeloablative doses of BU and fludarabine followed by allogeneic hematopoietic cell transplantation offer effective therapy for AML. We anticipated that pharmacokinetic targeting of i.v. BU to 5300 μm/L min/day × 4 (targeted i.v. BU and fludarabine (t-i.v. BU/Flu)) would limit nonrelapse mortality (...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Bone Marrow Transplant
Main Authors: Pidala, J, Kim, J, Anasetti, C, Kharfan-Dabaja, MA, Field, T, Perkins, J, Ayala, E, Perez, L, Fernandez, H
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5726256/
https://ncbi.nlm.nih.gov/pubmed/20711242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2010.190
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares